Reporting owner · CIK 0001035422
Ctt Pharmaceutical Holdings, Inc.
SEC Form 4 history across 1 companies, 12 transactions and 12 filings.
CEOCEOCTT PHARMACEUTICAL HOLDINGS, INC.
Open-market transaction mix100% buys12 buys · 0 sales
Available history · Aug 19, 2026 – Oct 06, 2026
Latest insider transactions
Form 4 filings from available history.Latest Form 4 facts
Quick context from source filings
Latest open-market transaction
buy at CTT PHARMACEUTICAL HOLDINGS, INC. on Oct 06, 2026 valued at $204.
Review SEC filingLatest sale
No open-market insider sale is available.
Monthly open-market activity
Last 3 reported months · purchases and sales
View exact monthly values
| Month | Purchases | Sales | Buy value | Sale value | Net value |
|---|---|---|---|---|---|
| Aug 2026 | 4 | 0 | $1,394.50 | $0.00 | $1,394.50 |
| Sep 2026 | 7 | 0 | $2,420.12 | $0.00 | $2,420.12 |
| Oct 2026 | 1 | 0 | $203.50 | $0.00 | $203.50 |
Net value is disclosed purchases minus sales, not profit. A dash means the value is unavailable.
Ownership and transaction size
Ownership and ticket size
Average P/S size$334.8
Median P/S size$329
Direct12
Indirect0
Oct 06, 2026buy
Filing-only signals
Deterministic matches in this insider's history
Associated companies
Companies in the disclosed reporting history
Open-market buy performance
90-day forward return on this insider's open-market purchases
Forward return is not available yet
No purchases currently have the price observations needed for a 90-day return. This may reflect incomplete price coverage or purchases that have not reached the return window.
Disclosed ownership
How reported shareholdings evolved
Non-derivative shares held after reported transactions—not stock prices or a complete portfolio.
12 observations · Aug 19, 2026 – Oct 6, 2026. Window ends at the latest available report, not today.
Selected observation · Oct 6, 20269,433,656 shares reported
Inspect transaction View exact observations and source transactions
| Transaction date | Shares held after | Filed | Source |
|---|---|---|---|
| Aug 19, 2026 | 9,365,456 | Aug 19, 2026 | View transaction |
| Aug 20, 2026 | 9,378,656 | Aug 20, 2026 | View transaction |
| Aug 24, 2026 | 9,360,756 | Aug 25, 2026 | View transaction |
| Aug 31, 2026 | 9,384,256 | Aug 31, 2026 | View transaction |
| Sep 2, 2026 | 9,387,256 | Sep 2, 2026 | View transaction |
| Sep 4, 2026 | 9,397,056 | Sep 4, 2026 | View transaction |
| Sep 10, 2026 | 9,400,556 | Sep 10, 2026 | View transaction |
| Sep 16, 2026 | 9,414,456 | Sep 16, 2026 | View transaction |
| Sep 22, 2026 | 1,056,800 | Sep 22, 2026 | View transaction |
| Sep 22, 2026 | 9,424,556 | Sep 29, 2026 | Amended transaction |
| Sep 28, 2026 | 9,429,956 | Sep 28, 2026 | View transaction |
| Oct 6, 2026 | 9,433,656 | Oct 6, 2026 | View transaction |
Securities and direct/indirect ownership contexts are kept separate and never summed. Joint filings may associate the same disclosed row with multiple owners. Unknown values are omitted, not treated as zero. Lines connect observations for readability; they do not establish holdings between filings, cost basis, or current ownership. Amendments and stock splits require reviewing the source.
Ctt Pharmaceutical Holdings, Inc. Insider Activity FAQ
SEC Form 4 context
Who is Ctt Pharmaceutical Holdings, Inc.?
Ctt Pharmaceutical Holdings, Inc. is a reporting owner in SEC Form 4 filings with reporting owner CIK 0001035422.
Which companies has Ctt Pharmaceutical Holdings, Inc. reported transactions for?
CTT PHARMACEUTICAL HOLDINGS, INC.
When was Ctt Pharmaceutical Holdings, Inc.'s latest insider buy?
buy at CTT PHARMACEUTICAL HOLDINGS, INC. on Oct 06, 2026 valued at $204.
When was Ctt Pharmaceutical Holdings, Inc.'s latest insider sale?
No open-market insider sale is available for this period.
Where can I see the original SEC filings?
Each transaction row links directly to the source SEC filing so the reported Form 4 details can be reviewed.
Are performance metrics included?
The profile shows average and median 90-day stock returns after open-market purchases when price coverage is available. These are unadjusted stock returns, not realized trading gains. Win rates, benchmark-adjusted returns and conviction scores are not calculated.